TargetCancer Foundation (TCF) promotes the development of lifesaving treatment protocols for rare cancers. TCF directly supports initiatives at the forefront of rare cancer treatment by funding innovative research, fostering medical collaborations, and raising awareness among scientists, clinicians, and patients. Founded by a rare cancer patient, TCF also works closely with the patient community and other rare cancer advocacy organizations to promote community, scientific, and educational opportunities for patients and families facing a rare cancer diagnosis.
